Avenue Therapeutics ATXI
OTC ATXI
$0.40 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Avenue Therapeutics (ATXI) Share-based Compensation (2016 - 2026)

Updated

Avenue Therapeutics (ATXI) reported Share-based Compensation of $61,000 for Q2 2026, down 65.1% from $175,000 a year earlier and unchanged from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Share-based Compensation (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Avenue Therapeutics' Share-based Compensation came in at $427,000, down 64.8% year-over-year; for FY2025, it came in at $665,000, down 46.2% from FY2024.

  • Share-based Compensation has a five-year compound annual growth rate of -1.3% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $1.24 million in FY2024 (+36.4%), $906,000 in FY2023 (+39.6%), $649,000 in FY2022 (+46.8%) and $442,000 in FY2021 (-37.7%).
  • Five-year quarterly Share-based Compensation spans a low of $11,000 in Q1 2023 and a high of $569,000 in Q1 2022.
  • Year over year, Share-based Compensation has now declined in each of the last six quarters, with an average decline of 29.8% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q2 2024 (growth of 611.1%); the low point was Q1 2023 (a decline of 98.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $61,000 (Q1 2026), $142,000 (Q4 2025) and $163,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 357.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 166.00 Mn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 231.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 249.00 Mn
10 Avenue Therapeutics 1.27 Mn -9.65 Mn - 61,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61,000.00
Mar 31, 2026 61,000.00
Dec 31, 2025 142,000.00
Sep 30, 2025 163,000.00
Jun 30, 2025 175,000.00
Mar 31, 2025 185,000.00
Dec 31, 2024 522,000.00
Sep 30, 2024 331,000.00
Jun 30, 2024 192,000.00
Mar 31, 2024 191,000.00
Dec 31, 2023 307,000.00
Sep 30, 2023 561,000.00
Jun 30, 2023 27,000.00
Mar 31, 2023 11,000.00
Dec 31, 2022 12,000.00
Sep 30, 2022 25,000.00
Jun 30, 2022 43,000.00
Mar 31, 2022 569,000.00
Dec 31, 2021 143,000.00
Sep 30, 2021 69,000.00
API Access

Avenue Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ATXI&period=max&api_key=YOUR_API_KEY